Clovis Oncology reported $122.24M in Cash and Equivalent for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Abbvie ABBV:US $ 6098M 3648M
Acadia Pharmaceuticals ACAD:US $ 204.92M 57.48M
Acorda Therapeutics ACOR:US $ 31.87M 13.76M
Agenus AGEN:US $ 247.71M 44.22M
Agios Pharmaceuticals AGIO:US $ 80.03M 123.1M
Anika Therapeutics ANIK:US $ 90.32M 4.06M
Arrowhead Research ARWR:US $ 86.41M 5.18M
AstraZeneca AZN:LN 5762M 567M
Astrazeneca AZN:US $ 5762M 567M
Cerulean Pharma CERU:US $ 39.32M 12.36M
Clovis Oncology CLVS:US $ 122.24M 21.19M
Eli Lilly And LLY:US $ 2459.2M 1359.3M
Enanta Pharmaceuticals ENTA:US $ 40.99M 58.08M
Esperion Therapeutics ESPR:US $ 150.36M 58.53M
GlaxoSmithKline GSK:LN 10967M 6693M
Halozyme Therapeutics HALO:US $ 117.84M 0.88M
Heron Therapeutics HRTX:US $ 56.91M 33.63M
Insmed INSM:US $ 515.7M 201.08M
Intrexon XON:US $ 40.32M 2.6M
Ligand Pharmaceuticals LGND:US $ 14.99M 4.53M
Merk MRK:US $ 8556M 460M
Mirati Therapeutics MRTX:US $ 293.42M 100.32M
Neurocrine Biosciences NBIX:US $ 270.2M 70.6M
Novartis NOVN:VX SF 13852M 1445M
Pfizer PFE:US $ 2470M 526M
Puma Biotechnology PBYI:US $ 63.91M 0.78M
Rigel Pharmaceuticals RIGL:US $ 24.68M 5.79M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Seattle Genetics SGEN:US $ 261M 163.84M
Ultragenyx Pharmaceutical RARE:US $ 153.99M 153.6M
Veracyte VCYT:US $ 163.62M 9.58M
YTE INCY:US $ 2256.76M 199.32M